VF
OCUL icon

Virtu Financial’s Ocular Therapeutix OCUL Stock Holding History

Virtu Financial’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,560
Closed -$377K – 2062
2026
Q1 		$377K Sell
44,560
-21,067
-32% -$201K 0.02% 708
2025
Q4 		$797K Buy
65,627
+54,117
+470% +$657K 0.03% 430
2025
Q3 		$135K Buy
+11,510
New +$138K 0.01% 990
2024
Q1 		– Sell
-62,066
Closed -$277K – 1892
2023
Q4 		$277K Buy
+62,066
New +$184K 0.02% 634
2023
Q3 		– Sell
-13,383
Closed -$69K – 1705
2023
Q2 		$69K Buy
+13,383
New +$79.6K 0.01% 1094
2021
Q3 		– Sell
-12,641
Closed -$179K – 1826
2021
Q2 		$179K Sell
12,641
-3,297
-21% -$50.1K 0.02% 1043
2021
Q1 		$262K Buy
+15,938
New +$307K 0.02% 892
2020
Q4 		– Sell
-19,459
Closed -$148K – 1687
2020
Q3 		$148K Buy
+19,459
New +$162K 0.03% 654
2019
Q4 		$189K Buy
47,820
+37,735
+374% +$131K 0.02% 959
2019
Q3 		$31K Buy
+10,085
New +$45.1K ﹤0.01% 1250
2018
Q3 		– Sell
-20,672
Closed -$140K – 1988
2018
Q2 		$140K Buy
20,672
+533
+3% +$3.66K 0.01% 1589
2018
Q1 		$131K Sell
20,139
-42,881
-68% -$241K 0.01% 1508
2017
Q4 		$280K Buy
+63,020
New +$322K 0.01% 1328

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Virtu Financial's OCUL Position: Q2 2026 in Review

Virtu Financial sold out of Ocular Therapeutix (OCUL) in Q2 2026, closing a stake of 44,560 shares — an estimated $377K sold.

Virtu Financial first reported a position in OCUL in Q4 2017 and held it in 13 quarters. The position peaked at $797K in Q4 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Virtu Financial reported no remaining Ocular Therapeutix position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 44,560 Ocular Therapeutix shares in Q2 2026, an estimated $377K.
  • Virtu Financial first reported a position in Ocular Therapeutix in Q4 2017 and held it in 13 quarters.
  • Virtu Financial's Ocular Therapeutix position peaked at $797K in Q4 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.